NORML
FEBRUARY 16, 2021
“This study demonstrates that treatment with THC-rich cannabis in patients with mild to moderate UC is associated with clinical improvement.". The post Clinical Trial: Cannabis Inhalation Associated with Clinical in Patients with Ulcerative Colitis appeared first on NORML.
NORML
FEBRUARY 4, 2021
“In this study, we have demonstrated for the first time in a placebo-controlled trial that cannabinoid treatment has the potential to decrease disruptive behaviors associated with ASD, with acceptable tolerability.".
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
MAY 26, 2020
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.
Veriheal
JUNE 17, 2021
However, there has not been a clinical trial assessing the efficacy of cannabis for migraines, at least not until now. Science Alert has announced that the first clinical trial for cannabis as a migraine treatment is underway. The First Clinical Trial for Migraines and Cannabis.
NORML
MAY 21, 2019
.” Researchers concluded, “CBD’s potential to reduce cue-induced craving and anxiety provides a strong basis for further investigation of this phytocannabinoid as a treatment option for opioid use disorder.” In clinical models, CBD administration has been shown to reduce cravings for tobacco.
NORML
DECEMBER 18, 2020
“This study provides evidence that the types of cannabis available in recreational and medical cannabis dispensaries might hold promise as an alternative treatment for PTSD. This study’s primary outcome supports the theory that cannabis should be [tested in clinical trials] as a potential therapeutic for PTSD.".
NORML
APRIL 30, 2020
CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.” ” This finding is hardly a surprise, as cannabis is well-established to mitigate pain in clinical models, particularly in patients with neuropathy. .”
Expert insights. Personalized for you.
246 
Let's personalize your content